Report Archive
All Research
Page 37 of 43 · 1027 reports
45/100
Keurig Dr Pepper: A Long-Term Business Owner's Perspective
Good assets, complex structure. KDP's North American beverage business and K-Cup coffee assets are solid, but the JDE Peet's acquisition and the planned subsequent split turn it into a capital-allocation trade that still has to be proven; conservative/fair/optimistic intrinsic value of $13–16 / $21–29 / $31–37, ideal buy below $20–22.
52/100
Intuitive Surgical: A Long-Term Business Owner's Research Report
The leader in robot-assisted surgery, with recurring revenue at 84% of the total and a moat built on its ecosystem rather than any single product. But as of 2026-05-22 the stock trades around $439.80 at a trailing P/E of roughly 53.4x, a clear premium to a reasonable intrinsic value of $250-340 with no margin of safety. Rating Watch: a superb business priced for a near-flawless decade.
50/100
Intuit Inc. Deep Value Analysis
A high-quality, capital-light, cash-generative tax and finance software platform with FY2025 revenue of $18.831 billion. The core thesis is that Intuit remains a durable platform, but TurboTax's moat is being retested by AI and policy change, making roughly $307 look closer to fair value than a clear bargain. Rating Watch: a strong business with insufficient margin of safety at the current price.
45/100
Insmed: A Deep-Dive Value Investing Research Report
A high-quality but high-expectation respiratory-specialty biotech. ARIKAYCE and BRINSUPRI are scarce respiratory assets, but at roughly $109.5 the stock already prices in multiple successes, owner earnings remain negative, and the margin of safety is thin. Rating Watch: a good company at an ungenerous price, with a fair buy range of $55–70.
47/100
In-Depth Value Research on IDEXX Laboratories
IDEXX Laboratories is a rare high-quality compounder in companion-animal diagnostics. Its 2025 free cash flow of about $1.057 billion and durable moat are impressive, but the price anchor of roughly $563 per share already discounts much of that excellence and leaves little margin of safety. Report rating Watch: keep it high on the watchlist and wait for better odds.
49/100
Long-Term Value Investment Research on SK hynix
SK hynix is the HBM leader whose competitive position and net-cash balance sheet have been materially upgraded by the AI memory supercycle. The core issue is valuation: at roughly ₩1,940,000 per share, the stock already prices in peak profits, with P/FCF around 53x and conservative intrinsic value only around ₩300,000 to ₩500,000, leaving no margin of safety. Research rating Watch: an excellent cyclical business to study and track, but not a value-investing buy at the current price.
43/100
Honeywell International: A Value-Investing Deep Dive
A high-quality industrial-technology group whose certifications, installed base, and aftermarket form a genuine moat, with 2025 adjusted FCF of $5.102 billion. But it sits in a restructuring phase, with Aerospace pending spin-off and PSS/WWS pending sale; at $223.8 the stock has already approached the low end of the optimistic range, leaving an inadequate margin of safety. Fair intrinsic value is $160–195 per share, rating Watch.
55/100
Alphabet Inc.: A Long-Term Business Owner's Study
A top-tier platform cash machine whose 2025 revenue cleared $400 billion for the first time, with a Search cash cow layered on a Cloud/AI upcycle. At roughly $383.47 the shares already sit near the top of the optimistic case, leaving thin margin of safety. Conservative intrinsic value is $90-120, fair value $200-260, optimistic $340-390. Rating Watch: a superb business worth tracking, but wait for the price rather than chase it.
47/100
Gilead Sciences In-Depth Value Investment Research
Gilead is a mature biopharma company with a real HIV moat and solid cash generation, with 2025 revenue of $29.443 billion and free cash flow of about $9.456 billion. At the current share price of about $130.50, investors are already paying in advance for acquisitions and the next pipeline handoff, leaving no obvious margin of safety. Research rating Watch: conservative intrinsic value is $70-90, fair value is $100-125, and the optimistic case is $145-165 per share.
43/100
GE HealthCare Technologies: A Deep Value Investment Analysis
A global leader in medical imaging and diagnostics, with 2025 revenue of $20.625 billion and free cash flow of $1.505 billion, carrying an above-average moat but no clear margin of safety at the current share price of about $64.33. Conservative intrinsic value is $50-58, fair value $65-80, and optimistic value $95-110. Rated Watch: for conservative investors this suits tracking rather than a heavy position.
Futu Holdings In-Depth Research Report
Futu Holdings is a cross-border digital brokerage with strong product capability, HK$11.3 billion of 2025 net profit, and ROE near 33%. But on 2026-05-22 the China Securities Regulatory Commission announced it intends to penalize Futu's cross-border operations, and that regulatory tail risk caps the valuation. At the current USD 124 there is no margin of safety against conservative value. Rating Watch: a high-quality platform whose long-term value distribution now hinges on a regulatory variable, not on operations.
55/100
Fortinet: An Investment Analysis Through a Long-Term Business Owner's Lens
A high-quality cybersecurity platform company with strong cash flow, ample net cash, and deep founder leadership, underpinned by solid service revenue and deferred revenue. But at 129.46 dollars it trades at roughly 39.5x TTM free cash flow, already near the top of the optimistic range, with a starting owner-earnings yield of just 2.2%-2.5% and no margin of safety. Rating Watch: an excellent business whose price leaves too little room for a conservative buyer.
50/100
Ferrovial NV In-Depth Value Research Report
Ferrovial is a high-quality infrastructure platform built around scarce North American toll-road and airport concession assets. The core thesis is that the business is durable and well managed, but the current price of about €58.28 per share already sits near the upper end of a reasonable intrinsic-value range of €50-€60, leaving an insufficient margin of safety and an ideal buy range of €38-€45. Research rating Watch: an excellent asset base, but not yet an attractive price for conservative value investors.
45/100
Fastenal Company: An In-Depth Value Study
A good business, good management, and good cash flow, but not a good price today. At about 38.5x PE and roughly 47x FCF, the market has already priced in too much future outperformance; against a fair intrinsic value range of $21–28, the current $43.53 leaves no margin of safety. Rated Watch.
40/100
Diamondback Energy: A Deep Value Analysis
FANG is a highly capable, cash-generative Permian Basin upstream operator that remains, at its core, a commodity business without pricing power. At around $205 per share, the stock sits close to fair value rather than cheap, leaving an inadequate margin of safety. Rating Watch: a reasonable buy range is $150-175 per share.
42/100
Electronic Arts: A Value-Investing Deep Dive
An understandable game publisher with solid cash flow and a fairly strong sports-franchise moat; FY2026 revenue of $7.531 billion, live services at 71% of revenue, in a net-cash position. But at $201.87 the stock is already pinned to the $210 acquisition consideration, so what ordinary investors are buying is mainly a 4% merger spread rather than long-term ownership, and the margin of safety is absent.
48/100
DexCom Investment Research Report
DexCom is one of the global leaders in continuous glucose monitoring (CGM), with long-term demand tailwinds and strong cash conversion. The core thesis is that this is a high-quality recurring-consumables medical device business, but the current price of $71.9 implies about 30.9x P/E and sits close to fair intrinsic value of $65-$75, while Abbott competition and the FDA warning letter leave limited margin of safety. Research rating Watch: a durable compounder candidate that deserves long-term tracking, but not yet a clearly discounted buy.
52/100
Datadog: A Value Investing Deep Dive
A high-quality cloud observability platform with 30% growth and strong cash flow, but at the current 218.04 dollars it trades 56%-129% above a fair intrinsic value of 95-140 dollars, leaving no margin of safety. Rating Watch: an excellent business whose price already prices in years of flawless execution.
46/100
Cintas Corporation Long-Term Owner's Perspective Research
Cintas is a high-quality business with a deep route-density moat, strong cash flow, and ROIC still improving from a high base. At the current price of $172.36, roughly 35.6x TTM earnings, my conservative intrinsic value range of only $100-130 makes it look more like a hold price than an undervalued entry point. Report rating Watch: an excellent company, but today's price does not offer a clear margin of safety.
42/100
CSX Corporation: A Deep-Dive Value Investing Study
One of the two Eastern rail duopolists, with a deep moat and strong cash flow; but at $45.9 the stock trades at 28.2x PE while fair value is only $26–34, a 35%–75% premium that leaves an insufficient margin of safety. Rating: Watch.
45/100
Cisco Systems: A Value-Investing Deep Dive
An understandable, cash-generative network-infrastructure platform, but at the current $118.20 it is priced like an AI growth stock (about 46x P/E); fair intrinsic value is only $60–80, the margin of safety is insufficient, rating Watch.
30/100
Bitmine Immersion Technologies: A Deep Value Study
BMNR is a high-beta ETH treasury stock loaded with fees, dilution, and governance risk rather than a high-quality compounder; adjusted EBITDA is still negative and the share count expanded roughly 125x in under a year. At a current price of $19.61, the stock trades at a modest discount to a reasonable intrinsic value of $21–25, but it is not cheap enough. Rating Watch: an asset-driven ETH proxy trading below company-stated holdings, yet short on business quality, governance discipline, and a real margin of safety.
42/100
ASE Technology Holding: An In-Depth Value Investing Study
The world's largest semiconductor packaging-and-testing (OSAT) leader, with advanced packaging benefiting from AI; 2026Q1 revenue rose +17% YoY and net profit +87%, but its capital-heavy, cyclical character is pronounced and the stock is already up 95% year-to-date, leaving an insufficient margin of safety; rating Watch.
50/100
Airbnb Value Investment Deep-Dive
Airbnb is a high-quality, cash-generative, asset-light platform business. At roughly $135.84, however, the stock lacks a sufficient margin of safety, with fair intrinsic value estimated at $135 to $165 and an ideal buy range of $95 to $115. Rating Watch: a durable platform worth following closely, but current pricing leaves limited downside protection for conservative value investors.